Sarcoidosis Board decisions

Your appeals have been dismissed as the Veteran has withdrawn all his pending appeals.

The Veteran's asbestosis was rated at 10% from July 24, 2015 to July 13, 2017. From July 13, 2017 onwards, the Veteran is granted a TDIU due to his service-connected disabilities preventing him from securing or following substantially gainful employment.

The Veteran's initial claim for an increased rating for sarcoid skin lesions was denied as the condition does not meet the criteria for a compensable evaluation under any applicable diagnostic code.

The Board has found that additional development is required for the Veteran's claims of sarcoidosis and asthma, including service connection for asthma secondary to sarcoidosis. The case is being remanded for further evaluation.

The Veteran's appeal for service connection for bilateral pes planus and sarcoidosis has been dismissed because the Veteran's attorney withdrew his appeals prior to a decision being made.

The Board has determined that the Veteran's sarcoidosis is related to his military service, granting service connection for this condition.

The Board denied the Veteran's claims for service connection for obstructive sleep apnea, colon cancer, and sarcoidosis due to asbestos exposure. The evidence did not establish a causal relationship between these conditions and his military service.

The Board has denied the Veteran's claim for service connection for sarcoidosis as new and relevant evidence was not received to warrant readjudication of the claim.

The Board denied service connection for a bilateral foot disorder, finding that the Veteran's current diagnosed conditions are less likely than not related to his military service.,Service connection for body pain was also denied due to lack of evidence showing causation or aggravation by sarcoidosis.

The Board has remanded the Veteran's claims for sarcoidosis and infectious hepatitis due to a lack of compliance with previous remand directives regarding VA examinations. The Veteran is advised to appear for any scheduled VA examinations.

The Board has remanded the Veteran's claim for obstructive sleep apnea, to include as secondary to service-connected sarcoidosis, due to insufficient development of evidence and failure to address whether VA satisfied its duty to assist in obtaining the Veteran's separation examination.

The Board has denied the Veteran's claims for service connection for sarcoidosis and diabetes mellitus, type II. The evidence does not support a finding that these conditions began during service or are related to in-service environmental exposures.

The Board has remanded the cases of sarcoidosis and asthma for additional development due to inadequate VA opinions.

The Board denied service connection for sarcoidosis and chronic urticaria, finding no current diagnosis or evidence of in-service disease or injury related to these conditions.

The reduction of the disability rating for service-connected sarcoidosis, lungs, history, from 10 percent to noncompensable, effective May 1, 2018, was not proper and the 10 percent rating is restored.

The Board has remanded the Veteran's claims for a rating in excess of 10 percent for his skin disability, including prior to May 15, 2020, and from that date. The reasons include inconsistencies with the medical evidence regarding systemic therapy use.

The Board has determined that the VA examination and medical opinions provided were not adequate for adjudication purposes, and thus the case is being remanded for further development.

Service connection for a right knee disability is denied.,Service connection for sarcoidosis, as due to conceded exposure to burn fields and other toxins, is granted.

The Veteran's service-connected pulmonary sarcoidosis is currently rated at 10 percent, and the Board found that his symptoms do not warrant a higher rating as they do not meet the criteria for a higher rating under any applicable diagnostic codes.

The Veteran's hypertension is granted as due to herbicide agent exposure. The claims for basal cell carcinoma, hypertension secondary to PTSD, erectile dysfunction secondary to PTSD, and sarcoidosis secondary to asthma/rhinitis are remanded.